Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Dysmorphophobia--symptom or diagnosis?].

U Wegner1, E M Meisenzahl, H J Möller

  • 1Psychiatrische Klinik, Ludwig Maximilians-Universität, München.

Der Nervenarzt
|May 8, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Non-Response to Antidepressants: Risk Factors and Therapeutic Possibilities.

Pharmacopsychiatry·2026
Same author

Vagal Nerve Stimulation-Modulation of the Anti-Inflammatory Response and Clinical Outcome in Psoriatic Arthritis or Ankylosing Spondylitis.

Mediators of inflammation·2021
Same author

Identification of voxel-based texture abnormalities as new biomarkers for schizophrenia and major depressive patients using layer-wise relevance propagation on deep learning decisions.

Psychiatry research. Neuroimaging·2021
Same author

The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis/macrophage activation syndrome - a systematic review.

Clinical and experimental immunology·2020
Same author

Short-term transcutaneous non-invasive vagus nerve stimulation may reduce disease activity and pro-inflammatory cytokines in rheumatoid arthritis: results of a pilot study.

Scandinavian journal of rheumatology·2020
Same author

Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation.

Alimentary pharmacology & therapeutics·2017

Dysmorphophobia, a psychiatric syndrome described in 1891, presents symptoms linked to other mental health disorders. This review discusses the term and classification challenges for dysmorphophobic signs.

Area of Science:

  • Psychiatry
  • Clinical Psychology

Background:

  • Dysmorphophobia, first described in 1891, is a psychiatric syndrome.
  • Dysmorphophobic symptoms frequently co-occur with other psychiatric conditions, complicating diagnosis.

Observation:

  • A case study of a 20-year-old patient exhibiting dysmorphophobic symptoms is presented.
  • The patient's presentation highlights the subjective nature of body image concerns.

Findings:

  • The theoretical review examines the historical context and evolution of the term dysmorphophobia.
  • Diagnostic classification issues arise when applying current criteria (ICD 10, DSM-III-R/DSM IV) to dysmorphophobic signs.

Implications:

  • Understanding dysmorphophobia is crucial for accurate psychiatric diagnosis and treatment.

Related Experiment Videos

  • Further research is needed to refine diagnostic criteria for body dysmorphic disorder and related conditions.